Form 8-K - Current report:
SEC Accession No. 0001104659-24-006963
Filing Date
2024-01-26
Accepted
2024-01-26 07:01:41
Documents
13
Period of Report
2024-01-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244193d1_8k.htm   iXBRL 8-K 26286
2 EXHIBIT 10.1 tm244193d1_ex10-1.htm EX-10.1 9259
  Complete submission text file 0001104659-24-006963.txt   209904

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnk-20240125.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20240125_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20240125_pre.xml EX-101.PRE 22366
7 EXTRACTED XBRL INSTANCE DOCUMENT tm244193d1_8k_htm.xml XML 3204
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 24564107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)